Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Avant announces phase II Peru-15 results

Oct. 3, 2002

Two Shionogi patents describe novel immunosuppressant agents

Oct. 2, 2002

Novel immunosuppressants in early development at Sumitomo

Oct. 1, 2002

Positive phase I results for AGI-1096 in prevention of transplant rejection

Oct. 1, 2002

TNX-901 for peanut allergy receives fast track status

Sep. 26, 2002

Tracvax protects against Chlamydia infection in preclinical studies

Sep. 26, 2002

Fujisawa and Pharmagenesis collaborate on triptolide derivatives

Sep. 25, 2002

Beneficial effects on chronic lung rejection reported for switching from ciclosporin to tacrolimus

Sep. 23, 2002

VX-148: a novel IMP dehydrogenase inhibitor with a favorable preclinical profile

Sep. 20, 2002

EMEA grants orphan drug status to APT-070 in kidney transplantation

Sep. 19, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...